Late onset familial Mediterranian fever: a clinical case
- Authors: Grinevich V.B.1, Gubonina I.V.1, Shperling M.I.1, Lapteva S.I.1, Kolodin T.V.1, Poluektov M.V.1
-
Affiliations:
- Military Medical Academy named after S.M. Kirov
- Issue: Vol 49, No 7 (2021)
- Pages: 496-502
- Section: CLINICAL CASES
- URL: https://almclinmed.ru/jour/article/view/1589
- DOI: https://doi.org/10.18786/2072-0505-2021-49-052
- ID: 1589
Cite item
Full Text
Abstract
Familial Mediterranean fever (FMF) is a rare genetic autosomal recessive disease typical for special ethnic groups, such as Arabs, Greeks, Armenians, Jews, Turks and other ethnicities inhabiting the Mediterranean coast. The characteristic clinical signs and symptoms of the disease are recurrent episodes of fever, associated with polyserositis, in particular, with benign (aseptic) peritonitis. The disease is caused by mutation in the MEFV gene encoding the synthesis of the protein pyrine, which leads to an uncontrolled release of pro-inflammatory cytokines by granulocytes. The criterion for the severe course of the disease is AA-renal amyloidosis associated with an unfavorable prognosis. Here we present a clinical case of classic FMF with high fever and abdominal pain syndrome. A 26-year-old Armenian patient had a sudden attack of fever and severe pain in the right iliac area several months before his first hospital admission. Non-steroid anti-inflammatory drugs and antispasmodics were unable to relieve the symptoms, with the attack ceasing spontaneously after 3 days from the beginning. Thereafter, the attacks recurred 1 to 2 times per month within a year. During hospital stay at the peak of the attack, peritoneal symptoms at abdominal palpation, together with neutrophilic leukocytosis and a significant increase in acute phase parameters of inflammation (C-reactive protein, fibrinogen, erythrocyte sedimentation rate) were found. Based on the characteristics of the complaints, past history, laboratory and instrumental results, we excluded infections, autoimmune and surgical disorders and made a decision to perform genetic testing to detect the MEFV gene mutation. Confirmation of the mutation has led to the definitive diagnosis of FMF. This clinical case is remarkable for its late onset, which is not typical for FMF. As a result, the patient was prescribed continuous therapy with сolchicine. Six months of the follow up have demonstrated a positive trend with no attacks during this period.
Keywords
About the authors
V. B. Grinevich
Military Medical Academy named after S.M. Kirov
Email: grinevich_vb@bk.ru
ORCID iD: 0000-0002-1095-8787
Vladimir B. Grinevich – MD, PhD, Professor, Head of 2nd Therapy Chair of Postgraduate Education
6А Akademika Lebedeva ul., Saint Petersburg, 194044
РоссияI. V. Gubonina
Military Medical Academy named after S.M. Kirov
Email: giv70@bk.ru
ORCID iD: 0000-0002-6302-7767
Irina V. Gubonina – MD, PhD, Associate Professor, 2nd Therapy Chair of Postgraduate Education
6А Akademika Lebedeva ul., Saint Petersburg, 194044
РоссияM. I. Shperling
Military Medical Academy named after S.M. Kirov
Author for correspondence.
Email: mersisaid@yandex.ru
ORCID iD: 0000-0002-3274-2290
Maxim I. Shperling – MD, Resident Physician, 1st Therapy Chair of Postgraduate Education
6А Akademika Lebedeva ul., Saint Petersburg, 194044
РоссияS. I. Lapteva
Military Medical Academy named after S.M. Kirov
Email: isilme93@gmail.com
Svetlana I. Lapteva – MD, Lecturer, 2nd Therapy Chair of Postgraduate Education
6А Akademika Lebedeva ul., Saint Petersburg, 194044
РоссияT. V. Kolodin
Military Medical Academy named after S.M. Kirov
Email: virionrock@yandex.ru
Timur V. Kolodin – MD, Head of Clinic, 2nd Therapy Chair of Postgraduate Education
6А Akademika Lebedeva ul., Saint Petersburg, 194044
РоссияM. V. Poluektov
Military Medical Academy named after S.M. Kirov
Email: max-poluektov@mail.ru
Maxim V. Poluektov – MD, PhD, Head of Therapy Department of Clinic, 2nd Therapy Chair of Postgraduate Education
6А Akademika Lebedeva ul., Saint Petersburg, 194044
РоссияReferences
- Федоров ЕС, Салугина СО, Кузьмина НН. Семейная средиземноморская лихорадка (периодическая болезнь): современный взгляд на проблему. Современная ревматология. 2013;7(1): 24–30. doi: 10.14412/1996-7012-2013-2363.
- Aksentijevich I, Kastner DL. Genetics of monogenic autoinflammatory diseases: past successes, future challenges. Nat Rev Rheumatol. 2011;7(8): 469–478. doi: 10.1038/nrrheum.2011.94.
- Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I. Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun. 2002;3(1): 43–45. doi: 10.1038/sj.gene.6363813.
- Yasar Bilge NS, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Yilmaz Oner S, Yildiz F, Yilmaz S, Ersozlu Bozkirli D, Aydin Tufan M, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Yildirim Cetin G, Erten S, Gonullu E, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Sayarlioglu M, Cınar M, Kasifoglu T. Comparison of early versus late onset familial Mediterranean fever. Int J Rheum Dis. 2018;21(4): 880–884. doi: 10.1111/1756-185X.13259.
- Touitou I. Standardized testing for mutations in familial Mediterranean fever. Clin Chem. 2003;49(11): 1781–1782. doi: 10.1373/clinchem.2003.025791.
- Terreri MTRA, Bernardo WM, Len CA, Almeida da Silva CA, Ribeiro de Magalhães CM, Sacchetti SB, Ferriani VPL, Piotto DGP, de Souza Cavalcanti A, Pantoja de Moraes AJ, Sztajnbok FR, Knupp Feitosa de Oliveira S, Arruda Campos LM, Bandeira M, Teixeira Santos FPS, Saad Magalhães C. Guidelines for the management and treatment of periodic fever syndromes: periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome. Rev Bras Reumatol Engl Ed. 2016;56(1): 52–57. English, Portuguese. doi: 10.1016/j.rbre.2015.09.004.
- Лобанова ОС, Волошинова ЕВ. Некоторые особенности течения семейной средиземноморской лихорадки, осложненной развитием АА-амилоидоза. Архивъ внутренней медицины. 2015;(1): 7–11. doi: 10.20514/2226-6704-2015-0-1-7-11.
- Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol. 2011;7(2): 105–112. doi: 10.1038/nrrheum.2010.181.
- Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40(10): 1879–1885. doi: 10.1002/art.1780401023.
- Желябина ОВ, Елисеев МС, Чикина МН. Наследственные периодические лихорадки в практике взрослого ревматолога. Современная ревматология. 2018;12(1): 78–84. doi: 10.14412/1996-7012-2018-1-78-84.
- Рамеев ВВ, Симонян АХ, Саркисова ИА, Рамеева АС, Козловская ЛВ. Амилоидоз и наследственные периодические аутовоспалительные синдромы. Клиницист. 2008;3(2): 6–15.
- Ozen S. Familial mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2003;162(7–8): 449–454. doi: 10.1007/s00431-003-1223-x.
- Yüksel S, Yalçinkaya F, Acar B, Ozçakar ZB, Oztürk B, Ekim M. Clinical improvement with infliximab in a child with amyloidosis secondary to familial Mediterranean fever. Rheumatology (Oxford). 2006;45(10): 1307–1308. doi: 10.1093/rheumatology/kel250.
- Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Perski O, Bornstein G, Grossman C, Harari G, Lidar M, Livneh A. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2017;69(4): 854–862. doi: 10.1002/art.39995.
- Абрамян РА, Авагян ГС, Абрамян ЛР. Особенности течения беременности и ведения беременных при периодической болезни. Вестник Российского университета дружбы народов. Серия: Медицина. 2011;(S5): 164–170.
- Клинические рекомендации по диагностике и лечению болезни Крона у взрослых (проект). Колопроктология. 2020;19(2): 8–38. doi: 10.33878/2073-7556-2020-19-2-8-38.